

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 8.90386990 |
| 2 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 6.78522549 |
| 3 | gamma-aminobutyric acid transport (GO:0015812) | 5.60550870 |
| 4 | cell proliferation in forebrain (GO:0021846) | 5.31864032 |
| 5 | cellular anion homeostasis (GO:0030002) | 4.99731885 |
| 6 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.93718446 |
| 7 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.84652384 |
| 8 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.84652384 |
| 9 | tooth mineralization (GO:0034505) | 4.76931372 |
| 10 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.70305878 |
| 11 | cellular response to ATP (GO:0071318) | 4.65201744 |
| 12 | positive regulation of fatty acid oxidation (GO:0046321) | 4.62645196 |
| 13 | regulation of sequestering of triglyceride (GO:0010889) | 4.59987641 |
| 14 | negative regulation of response to food (GO:0032096) | 4.53243346 |
| 15 | negative regulation of appetite (GO:0032099) | 4.53243346 |
| 16 | homocysteine metabolic process (GO:0050667) | 4.47242460 |
| 17 | primary amino compound metabolic process (GO:1901160) | 4.40030618 |
| 18 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.36057091 |
| 19 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 4.34338164 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.32309124 |
| 21 | otic vesicle formation (GO:0030916) | 4.20853090 |
| 22 | sulfation (GO:0051923) | 4.16516940 |
| 23 | regulation of glomerulus development (GO:0090192) | 4.07813632 |
| 24 | postsynaptic membrane organization (GO:0001941) | 4.01763923 |
| 25 | regulation of DNA endoreduplication (GO:0032875) | 3.93834637 |
| 26 | phosphate ion homeostasis (GO:0055062) | 3.89634378 |
| 27 | trivalent inorganic anion homeostasis (GO:0072506) | 3.89634378 |
| 28 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.74270998 |
| 29 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.74253990 |
| 30 | kynurenine metabolic process (GO:0070189) | 3.74066174 |
| 31 | white fat cell differentiation (GO:0050872) | 3.53705383 |
| 32 | transmission of nerve impulse (GO:0019226) | 3.53178174 |
| 33 | tryptophan catabolic process (GO:0006569) | 3.51365722 |
| 34 | indole-containing compound catabolic process (GO:0042436) | 3.51365722 |
| 35 | indolalkylamine catabolic process (GO:0046218) | 3.51365722 |
| 36 | inner ear receptor cell development (GO:0060119) | 3.42531581 |
| 37 | behavioral fear response (GO:0001662) | 3.42325769 |
| 38 | behavioral defense response (GO:0002209) | 3.42325769 |
| 39 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.35423220 |
| 40 | fear response (GO:0042596) | 3.34889952 |
| 41 | regulation of response to food (GO:0032095) | 3.33842167 |
| 42 | serotonin metabolic process (GO:0042428) | 3.33655825 |
| 43 | negative regulation of response to extracellular stimulus (GO:0032105) | 3.26773719 |
| 44 | negative regulation of response to nutrient levels (GO:0032108) | 3.26773719 |
| 45 | indole-containing compound metabolic process (GO:0042430) | 3.25690624 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 3.16550389 |
| 47 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.12994380 |
| 48 | regulation of appetite (GO:0032098) | 3.12374419 |
| 49 | gonadal mesoderm development (GO:0007506) | 3.11706653 |
| 50 | vitamin catabolic process (GO:0009111) | 3.11270920 |
| 51 | fat-soluble vitamin catabolic process (GO:0042363) | 3.11270920 |
| 52 | somite development (GO:0061053) | 3.07960924 |
| 53 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 3.06445371 |
| 54 | regulation of cholesterol storage (GO:0010885) | 3.05540801 |
| 55 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.98897644 |
| 56 | protein complex biogenesis (GO:0070271) | 2.97778760 |
| 57 | positive regulation of metanephros development (GO:0072216) | 2.93159300 |
| 58 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.92337037 |
| 59 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.92337037 |
| 60 | NADH dehydrogenase complex assembly (GO:0010257) | 2.92337037 |
| 61 | chaperone-mediated protein transport (GO:0072321) | 2.89780810 |
| 62 | regulation of mesonephros development (GO:0061217) | 2.88172161 |
| 63 | protein polyglutamylation (GO:0018095) | 2.86564360 |
| 64 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.85971279 |
| 65 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.85853777 |
| 66 | ATP synthesis coupled proton transport (GO:0015986) | 2.85853777 |
| 67 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.83658711 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.82886313 |
| 69 | microtubule nucleation (GO:0007020) | 2.82267079 |
| 70 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.80756749 |
| 71 | cysteine metabolic process (GO:0006534) | 2.80522609 |
| 72 | serine family amino acid catabolic process (GO:0009071) | 2.80469617 |
| 73 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80204678 |
| 74 | parturition (GO:0007567) | 2.79898994 |
| 75 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.77139790 |
| 76 | membrane depolarization during action potential (GO:0086010) | 2.72923537 |
| 77 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.70701592 |
| 78 | regulation of transcription regulatory region DNA binding (GO:2000677) | 2.70016079 |
| 79 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.68914402 |
| 80 | galactose metabolic process (GO:0006012) | 2.68293206 |
| 81 | sulfur amino acid catabolic process (GO:0000098) | 2.65763500 |
| 82 | negative regulation of macrophage differentiation (GO:0045650) | 2.63035334 |
| 83 | tryptophan metabolic process (GO:0006568) | 2.62462840 |
| 84 | regulation of female receptivity (GO:0045924) | 2.61608341 |
| 85 | protein-cofactor linkage (GO:0018065) | 2.61338137 |
| 86 | opsonization (GO:0008228) | 2.60257554 |
| 87 | membrane repolarization during action potential (GO:0086011) | 2.59919679 |
| 88 | glyoxylate metabolic process (GO:0046487) | 2.59887306 |
| 89 | negative regulation of membrane potential (GO:0045837) | 2.59647770 |
| 90 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.58802064 |
| 91 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.58802064 |
| 92 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.57509154 |
| 93 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.56321266 |
| 94 | regulation of plasminogen activation (GO:0010755) | 2.52158746 |
| 95 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.51078619 |
| 96 | positive regulation of mitochondrial fission (GO:0090141) | 2.50301879 |
| 97 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.49496351 |
| 98 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.49496351 |
| 99 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.48883152 |
| 100 | mesenchymal to epithelial transition (GO:0060231) | 2.48510627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.79071985 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.92615370 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.07595319 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.78849459 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.58919357 |
| 6 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.52940175 |
| 7 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.43899992 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.39744855 |
| 9 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.38780932 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.35189908 |
| 11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.28955089 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28611071 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27299880 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.26731208 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18672745 |
| 16 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.09975762 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.03723051 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.99062287 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.96995293 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85268559 |
| 21 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.80367848 |
| 22 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.78694575 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77006815 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.76351482 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.75978263 |
| 26 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.73432041 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72844281 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.71666556 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70952332 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70952332 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.69901761 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62344031 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58160646 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.57662725 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.57335081 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54562598 |
| 37 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51206420 |
| 38 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.50903552 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.49475271 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47581103 |
| 41 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.41732997 |
| 42 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.40565323 |
| 43 | NCOR_22424771_ChIP-Seq_293T_Human | 1.40101426 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.39022741 |
| 45 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.38603998 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37754646 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36031079 |
| 48 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33814190 |
| 49 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33250500 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32101162 |
| 51 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30421152 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30037291 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.28297388 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26716419 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26716419 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25186234 |
| 57 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.24388406 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22694996 |
| 59 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.22386441 |
| 60 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21603575 |
| 61 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.21105868 |
| 62 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.20422864 |
| 63 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16672024 |
| 64 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.14701043 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11035960 |
| 66 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10310991 |
| 67 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09904332 |
| 68 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07181950 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04996296 |
| 70 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.03175724 |
| 71 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.02488174 |
| 72 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01495591 |
| 73 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98866541 |
| 74 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97307244 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96942059 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96415482 |
| 77 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96132793 |
| 78 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95722825 |
| 79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94511075 |
| 80 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94472748 |
| 81 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.91073531 |
| 82 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.90620795 |
| 83 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.90616627 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89570032 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89522788 |
| 86 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.89409750 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89205159 |
| 88 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89151749 |
| 89 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89151749 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88083663 |
| 91 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.87838490 |
| 92 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.86074399 |
| 93 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.86067092 |
| 94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.85824507 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84939844 |
| 96 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84075371 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84072949 |
| 98 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83739086 |
| 99 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83094304 |
| 100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.83043354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.22765600 |
| 2 | MP0003646_muscle_fatigue | 3.68458235 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.33646812 |
| 4 | MP0002160_abnormal_reproductive_system | 2.94254559 |
| 5 | MP0004130_abnormal_muscle_cell | 2.91958816 |
| 6 | MP0005646_abnormal_pituitary_gland | 2.76618600 |
| 7 | MP0004885_abnormal_endolymph | 2.71866149 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.52992072 |
| 9 | MP0004142_abnormal_muscle_tone | 2.47411365 |
| 10 | MP0001485_abnormal_pinna_reflex | 2.30420324 |
| 11 | MP0004134_abnormal_chest_morphology | 2.18631515 |
| 12 | MP0002736_abnormal_nociception_after | 2.08820164 |
| 13 | MP0001440_abnormal_grooming_behavior | 2.08597036 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.00524696 |
| 15 | MP0001968_abnormal_touch/_nociception | 1.96472181 |
| 16 | MP0005389_reproductive_system_phenotype | 1.94637943 |
| 17 | MP0008872_abnormal_physiological_respon | 1.91275666 |
| 18 | MP0000631_abnormal_neuroendocrine_gland | 1.90721597 |
| 19 | MP0003879_abnormal_hair_cell | 1.89918204 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 1.89772408 |
| 21 | MP0002272_abnormal_nervous_system | 1.87297555 |
| 22 | MP0004133_heterotaxia | 1.86770347 |
| 23 | MP0004147_increased_porphyrin_level | 1.81275215 |
| 24 | MP0005670_abnormal_white_adipose | 1.73068877 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.68028089 |
| 26 | MP0000049_abnormal_middle_ear | 1.62943536 |
| 27 | MP0003942_abnormal_urinary_system | 1.62385439 |
| 28 | MP0003011_delayed_dark_adaptation | 1.61459251 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.60257293 |
| 30 | MP0009745_abnormal_behavioral_response | 1.59020828 |
| 31 | MP0003122_maternal_imprinting | 1.57230486 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.53617226 |
| 33 | MP0002089_abnormal_postnatal_growth/wei | 1.53038418 |
| 34 | MP0001853_heart_inflammation | 1.50871480 |
| 35 | MP0002184_abnormal_innervation | 1.50767631 |
| 36 | MP0002938_white_spotting | 1.50091924 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.43566057 |
| 38 | MP0005360_urolithiasis | 1.43291066 |
| 39 | MP0000026_abnormal_inner_ear | 1.43077050 |
| 40 | MP0000778_abnormal_nervous_system | 1.40965392 |
| 41 | MP0009250_abnormal_appendicular_skeleto | 1.40729854 |
| 42 | MP0009379_abnormal_foot_pigmentation | 1.38627075 |
| 43 | MP0003878_abnormal_ear_physiology | 1.36788005 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.36788005 |
| 45 | MP0000534_abnormal_ureter_morphology | 1.36614157 |
| 46 | MP0004742_abnormal_vestibular_system | 1.35217663 |
| 47 | MP0009046_muscle_twitch | 1.33984868 |
| 48 | MP0001542_abnormal_bone_strength | 1.33459663 |
| 49 | MP0001486_abnormal_startle_reflex | 1.32232260 |
| 50 | MP0008789_abnormal_olfactory_epithelium | 1.31103441 |
| 51 | MP0001963_abnormal_hearing_physiology | 1.28309586 |
| 52 | MP0000678_abnormal_parathyroid_gland | 1.28289455 |
| 53 | MP0001970_abnormal_pain_threshold | 1.26513856 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.23228879 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.22162780 |
| 56 | MP0002064_seizures | 1.21514451 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.19708096 |
| 58 | MP0003638_abnormal_response/metabolism_ | 1.19128765 |
| 59 | MP0001919_abnormal_reproductive_system | 1.19055409 |
| 60 | MP0002063_abnormal_learning/memory/cond | 1.15268496 |
| 61 | MP0004270_analgesia | 1.14904365 |
| 62 | MP0003635_abnormal_synaptic_transmissio | 1.13255267 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 1.12600902 |
| 64 | MP0003938_abnormal_ear_development | 1.10215497 |
| 65 | MP0008995_early_reproductive_senescence | 1.08674972 |
| 66 | MP0002752_abnormal_somatic_nervous | 1.08556404 |
| 67 | MP0005423_abnormal_somatic_nervous | 1.00776771 |
| 68 | MP0005195_abnormal_posterior_eye | 0.97019824 |
| 69 | MP0003121_genomic_imprinting | 0.94367462 |
| 70 | MP0002557_abnormal_social/conspecific_i | 0.94005127 |
| 71 | MP0000537_abnormal_urethra_morphology | 0.92552386 |
| 72 | MP0004019_abnormal_vitamin_homeostasis | 0.92200925 |
| 73 | MP0005253_abnormal_eye_physiology | 0.90149794 |
| 74 | MP0001293_anophthalmia | 0.89967411 |
| 75 | MP0009053_abnormal_anal_canal | 0.88563167 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.88257944 |
| 77 | MP0004215_abnormal_myocardial_fiber | 0.87943111 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.87370728 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.86687455 |
| 80 | MP0010386_abnormal_urinary_bladder | 0.86584935 |
| 81 | MP0002163_abnormal_gland_morphology | 0.86084902 |
| 82 | MP0005332_abnormal_amino_acid | 0.85433123 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.84742252 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 0.83495390 |
| 85 | MP0003787_abnormal_imprinting | 0.82046183 |
| 86 | MP0000955_abnormal_spinal_cord | 0.82032247 |
| 87 | MP0003186_abnormal_redox_activity | 0.79450027 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.78016082 |
| 89 | MP0002067_abnormal_sensory_capabilities | 0.77141247 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.75699397 |
| 91 | MP0001905_abnormal_dopamine_level | 0.74586132 |
| 92 | MP0005499_abnormal_olfactory_system | 0.72396597 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.72396597 |
| 94 | MP0002249_abnormal_larynx_morphology | 0.72037520 |
| 95 | MP0002229_neurodegeneration | 0.71241146 |
| 96 | MP0008569_lethality_at_weaning | 0.71179651 |
| 97 | MP0003195_calcinosis | 0.70953307 |
| 98 | MP0008877_abnormal_DNA_methylation | 0.70361384 |
| 99 | MP0003880_abnormal_central_pattern | 0.69026411 |
| 100 | MP0002882_abnormal_neuron_morphology | 0.68588540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pendular nystagmus (HP:0012043) | 4.42961669 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 4.33999569 |
| 3 | Hyperalaninemia (HP:0003348) | 4.33999569 |
| 4 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.33999569 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.25058611 |
| 6 | Congenital sensorineural hearing impairment (HP:0008527) | 3.96167135 |
| 7 | True hermaphroditism (HP:0010459) | 3.83577004 |
| 8 | Genetic anticipation (HP:0003743) | 3.67977223 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.66270430 |
| 10 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.57239159 |
| 11 | Abnormality of homocysteine metabolism (HP:0010919) | 3.51440042 |
| 12 | Homocystinuria (HP:0002156) | 3.51440042 |
| 13 | Chronic hepatic failure (HP:0100626) | 3.49455311 |
| 14 | Agitation (HP:0000713) | 3.38998852 |
| 15 | Abnormality of cochlea (HP:0000375) | 3.30783831 |
| 16 | 3-Methylglutaconic aciduria (HP:0003535) | 3.28981243 |
| 17 | Septo-optic dysplasia (HP:0100842) | 3.12412217 |
| 18 | Abolished electroretinogram (ERG) (HP:0000550) | 3.04378639 |
| 19 | Pancreatic cysts (HP:0001737) | 3.03135976 |
| 20 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.86778906 |
| 21 | Methylmalonic acidemia (HP:0002912) | 2.86610478 |
| 22 | Stenosis of the external auditory canal (HP:0000402) | 2.85295187 |
| 23 | Visual hallucinations (HP:0002367) | 2.78029240 |
| 24 | Porencephaly (HP:0002132) | 2.76719050 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 2.74065198 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 2.74065198 |
| 27 | Reticulocytopenia (HP:0001896) | 2.72307310 |
| 28 | Action tremor (HP:0002345) | 2.70559172 |
| 29 | Asplenia (HP:0001746) | 2.69845162 |
| 30 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.68950898 |
| 31 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.65776593 |
| 32 | Nephronophthisis (HP:0000090) | 2.65222398 |
| 33 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.65099722 |
| 34 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.55341600 |
| 35 | Osteomalacia (HP:0002749) | 2.55010848 |
| 36 | Short tibia (HP:0005736) | 2.48930454 |
| 37 | Morphological abnormality of the inner ear (HP:0011390) | 2.47211953 |
| 38 | Keratoconus (HP:0000563) | 2.45751022 |
| 39 | Increased corneal curvature (HP:0100692) | 2.45751022 |
| 40 | Confusion (HP:0001289) | 2.45705938 |
| 41 | Sclerocornea (HP:0000647) | 2.44275191 |
| 42 | Anencephaly (HP:0002323) | 2.43768259 |
| 43 | Optic nerve hypoplasia (HP:0000609) | 2.43697994 |
| 44 | Hemiparesis (HP:0001269) | 2.43453664 |
| 45 | Abnormality of the nasal septum (HP:0000419) | 2.39635625 |
| 46 | Absent thumb (HP:0009777) | 2.37762028 |
| 47 | Ectopic kidney (HP:0000086) | 2.35667792 |
| 48 | Male pseudohermaphroditism (HP:0000037) | 2.35655983 |
| 49 | Pigmentary retinal degeneration (HP:0001146) | 2.32596203 |
| 50 | Chorioretinal atrophy (HP:0000533) | 2.32209319 |
| 51 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.31791742 |
| 52 | Short femoral neck (HP:0100864) | 2.30514283 |
| 53 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.30499798 |
| 54 | Abnormality of the renal collecting system (HP:0004742) | 2.27844742 |
| 55 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.27582870 |
| 56 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.27144875 |
| 57 | Methylmalonic aciduria (HP:0012120) | 2.26212199 |
| 58 | Abnormality of binocular vision (HP:0011514) | 2.25030441 |
| 59 | Diplopia (HP:0000651) | 2.25030441 |
| 60 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20075467 |
| 61 | Cystic liver disease (HP:0006706) | 2.19913109 |
| 62 | Oligomenorrhea (HP:0000876) | 2.17363363 |
| 63 | Maternal diabetes (HP:0009800) | 2.14738911 |
| 64 | Constricted visual fields (HP:0001133) | 2.13031858 |
| 65 | Abnormality of serum amino acid levels (HP:0003112) | 2.12586890 |
| 66 | Myotonia (HP:0002486) | 2.09270173 |
| 67 | Absent septum pellucidum (HP:0001331) | 2.08418499 |
| 68 | Severe visual impairment (HP:0001141) | 2.08172631 |
| 69 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.05889028 |
| 70 | Congenital stationary night blindness (HP:0007642) | 2.03265988 |
| 71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01552638 |
| 72 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.00701219 |
| 73 | Abnormality of renal resorption (HP:0011038) | 1.99280806 |
| 74 | Long nose (HP:0003189) | 1.97685130 |
| 75 | Decreased central vision (HP:0007663) | 1.95444747 |
| 76 | Abnormality of the renal medulla (HP:0100957) | 1.95035785 |
| 77 | Abnormality of DNA repair (HP:0003254) | 1.94663683 |
| 78 | Attenuation of retinal blood vessels (HP:0007843) | 1.94244374 |
| 79 | Hemiplegia (HP:0002301) | 1.91771557 |
| 80 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.91362657 |
| 81 | Short 4th metacarpal (HP:0010044) | 1.91362657 |
| 82 | Furrowed tongue (HP:0000221) | 1.90793056 |
| 83 | Fibular hypoplasia (HP:0003038) | 1.88463129 |
| 84 | Morphological abnormality of the middle ear (HP:0008609) | 1.87305580 |
| 85 | Short 1st metacarpal (HP:0010034) | 1.86928175 |
| 86 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.86928175 |
| 87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.86759098 |
| 88 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.84576588 |
| 89 | Abnormality of the corticospinal tract (HP:0002492) | 1.81049628 |
| 90 | Goiter (HP:0000853) | 1.81038698 |
| 91 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.80293656 |
| 92 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.79758496 |
| 93 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.79693689 |
| 94 | Hypoplasia of the uterus (HP:0000013) | 1.79063846 |
| 95 | Decreased circulating renin level (HP:0003351) | 1.76135668 |
| 96 | Mesomelia (HP:0003027) | 1.76035314 |
| 97 | Abnormal number of erythroid precursors (HP:0012131) | 1.74390584 |
| 98 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.72725544 |
| 99 | Abnormality of the 4th metacarpal (HP:0010012) | 1.70952832 |
| 100 | Abnormality of the labia minora (HP:0012880) | 1.70136735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.88405660 |
| 2 | ADRBK2 | 2.69999259 |
| 3 | GRK1 | 2.69767769 |
| 4 | MUSK | 2.56124121 |
| 5 | PINK1 | 2.51677637 |
| 6 | DYRK3 | 2.49511103 |
| 7 | WNK4 | 2.42066608 |
| 8 | DYRK2 | 2.40729947 |
| 9 | SGK494 | 2.30215462 |
| 10 | SGK223 | 2.30215462 |
| 11 | NTRK2 | 2.04025125 |
| 12 | SGK2 | 1.97241266 |
| 13 | PRKD2 | 1.94832893 |
| 14 | FRK | 1.89623329 |
| 15 | MAP3K11 | 1.85523179 |
| 16 | SIK2 | 1.74330155 |
| 17 | MAP4K2 | 1.71079289 |
| 18 | EPHB2 | 1.65593390 |
| 19 | TXK | 1.64829749 |
| 20 | VRK1 | 1.59675687 |
| 21 | TNIK | 1.58663226 |
| 22 | DAPK2 | 1.58015131 |
| 23 | PIK3CA | 1.55013388 |
| 24 | ACVR1B | 1.54334578 |
| 25 | SGK3 | 1.45537131 |
| 26 | MAP3K3 | 1.44401179 |
| 27 | WNK3 | 1.41605325 |
| 28 | RPS6KA2 | 1.35422163 |
| 29 | MAP3K12 | 1.29894545 |
| 30 | TYRO3 | 1.27688524 |
| 31 | AKT3 | 1.19280812 |
| 32 | RPS6KA6 | 1.16855689 |
| 33 | SGK1 | 1.15402813 |
| 34 | PRKCG | 1.12790190 |
| 35 | EPHA3 | 1.12327486 |
| 36 | CASK | 1.09337203 |
| 37 | RPS6KL1 | 1.04212983 |
| 38 | RPS6KC1 | 1.04212983 |
| 39 | RPS6KA4 | 1.02994938 |
| 40 | ADRBK1 | 1.00784996 |
| 41 | EPHA4 | 0.99044471 |
| 42 | ERBB2 | 0.96940710 |
| 43 | PRKCE | 0.96266042 |
| 44 | DYRK1B | 0.95221246 |
| 45 | GRK7 | 0.94189780 |
| 46 | CDC7 | 0.92649664 |
| 47 | PAK3 | 0.92010616 |
| 48 | NUAK1 | 0.90933623 |
| 49 | MAP3K4 | 0.90497049 |
| 50 | PHKG1 | 0.90443718 |
| 51 | PHKG2 | 0.90443718 |
| 52 | CSNK1A1 | 0.88541139 |
| 53 | HIPK2 | 0.87612817 |
| 54 | TAF1 | 0.83612976 |
| 55 | MAP2K7 | 0.83201748 |
| 56 | PLK2 | 0.82053890 |
| 57 | STK39 | 0.79546379 |
| 58 | VRK2 | 0.76175574 |
| 59 | MINK1 | 0.76153413 |
| 60 | CAMK1 | 0.76121617 |
| 61 | MARK1 | 0.75759229 |
| 62 | AURKA | 0.75256023 |
| 63 | PRKCI | 0.72481251 |
| 64 | CDK5 | 0.70303925 |
| 65 | MAP2K3 | 0.69884770 |
| 66 | NTRK3 | 0.68835942 |
| 67 | PRKACA | 0.67999509 |
| 68 | CAMKK2 | 0.67490645 |
| 69 | PKN1 | 0.66781915 |
| 70 | IRAK4 | 0.65279803 |
| 71 | PRKD1 | 0.65108248 |
| 72 | RPS6KA5 | 0.64909903 |
| 73 | MAPK13 | 0.61058034 |
| 74 | NLK | 0.58724883 |
| 75 | PRKCH | 0.54834900 |
| 76 | PRKCD | 0.54610878 |
| 77 | DYRK1A | 0.53767491 |
| 78 | ATR | 0.52121023 |
| 79 | INSRR | 0.51488927 |
| 80 | CAMK2A | 0.49772414 |
| 81 | TIE1 | 0.48476132 |
| 82 | PRKCA | 0.47948496 |
| 83 | TLK1 | 0.45644640 |
| 84 | GRK5 | 0.43807127 |
| 85 | PRKCQ | 0.43741216 |
| 86 | GRK6 | 0.43268358 |
| 87 | CDK9 | 0.42911169 |
| 88 | BCKDK | 0.42628574 |
| 89 | PRKCZ | 0.42009962 |
| 90 | RPS6KA1 | 0.41022080 |
| 91 | CSNK2A1 | 0.40310296 |
| 92 | NME1 | 0.39751659 |
| 93 | PNCK | 0.37494268 |
| 94 | BMPR1B | 0.34994228 |
| 95 | STK38L | 0.34757488 |
| 96 | MAP4K1 | 0.34245779 |
| 97 | BLK | 0.33892982 |
| 98 | DAPK3 | 0.33395540 |
| 99 | BRAF | 0.32812547 |
| 100 | CAMK4 | 0.32724291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.54926391 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.45347381 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.62880372 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.44096942 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.41314063 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.21387705 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.17974648 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.16601375 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.13178286 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.04539678 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.99452423 |
| 12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.95878876 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.90317531 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.86838109 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.86094282 |
| 16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.77196049 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.75867261 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65962845 |
| 19 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.64165249 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.63987219 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.60352804 |
| 22 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.57671124 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.55833724 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.48815842 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47414755 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.45919413 |
| 27 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.45376329 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.42794737 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41845260 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40539774 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39589121 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.38113986 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.37329531 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.36694024 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34835563 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34590119 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31447467 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28433497 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28003752 |
| 40 | RNA polymerase_Homo sapiens_hsa03020 | 1.26001609 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25021965 |
| 42 | Circadian entrainment_Homo sapiens_hsa04713 | 1.23953993 |
| 43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23603944 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17285793 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.15106097 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.13619498 |
| 47 | Melanoma_Homo sapiens_hsa05218 | 1.12366640 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.05029764 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02252123 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.01695723 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01499561 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00808084 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96492348 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 0.96381927 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93693187 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93684529 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.90390344 |
| 58 | DNA replication_Homo sapiens_hsa03030 | 0.90220729 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87798101 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86094170 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82520059 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80985620 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78277712 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77830250 |
| 65 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76359328 |
| 66 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74969526 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70064009 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65161470 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64608056 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63424665 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.62443344 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60114828 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58525168 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58333330 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57368836 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.56726728 |
| 77 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56103389 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54483144 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52304556 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51833165 |
| 81 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51389819 |
| 82 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51377966 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.48548365 |
| 84 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47505129 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43681943 |
| 86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41169422 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.39718292 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.39041505 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.39011839 |
| 90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38705273 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.37329442 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.36206139 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33611304 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.33490200 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33022495 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32048095 |
| 97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30859196 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28507929 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24426422 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22987219 |

